When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Why MannKind Shares Are Falling Today - AOL

    www.aol.com/news/why-mannkind-shares-falling...

    MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the New Drug Application ...

  3. Why MannKind Corporation Stock Is Tanking Again Today - AOL

    www.aol.com/news/why-mannkind-corporation-stock...

    For premium support please call: 800-290-4726 more ways to reach us

  4. Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL

  5. MannKind's Breathtaking News - AOL

    www.aol.com/news/2012-10-10-mannkinds...

    MannKind (NAS: MNKD) announced breathtaking news this week -- literally. The biotech completed patient recruitment for two phase 3 clinical trials for its insulin inhalant Afrezza. The ...

  6. KSWO-TV - Wikipedia

    en.wikipedia.org/wiki/KSWO-TV

    KSWO-TV (channel 7) is a television station licensed to Lawton, Oklahoma, United States, serving the western Texoma area as an affiliate of ABC and Telemundo.It is owned by Gray Media, which maintains a shared services agreement (SSA) with American Spirit Media, owner of Wichita Falls, Texas–licensed CBS affiliate KAUZ-TV (channel 6), for the provision of certain services.

  7. What's Behind MannKind's Incredible Run? - AOL

    www.aol.com/news/2013-03-13-whats-behind...

    For premium support please call: 800-290-4726 more ways to reach us

  8. News Main - AOL Sports

    lite.aol.com/news/us

    Today's Top U.S. News Story Attorneys are suing to keep 10 migrants out of Guantanamo Bay as others say they were abused there Civil rights attorneys are suing the Trump administration to prevent it from transferring 10 migrants detained in the U.S. to Guantanamo Bay, Cuba More »

  9. 2 Things to Watch at MannKind - AOL

    www.aol.com/news/2013-01-24-2-things-to-watch-at...

    With its fourth-quarter earnings report just around the corner, biotech company MannKind continues to inch its way toward an FDA decision regarding its ultra-rapid inhalable insulin product Afrezza.